Ownership

Christopher Rovaldi - Insider Trading & Ownership

Entity: Individual
Location: C/O Acceleron Pharma Inc., 128 Sidney St., Cambridge, MA
Summary: The estimated net worth of Christopher Rovaldi is at least $2.64M dollars as of February 19, 2025. Christopher Rovaldi is the Chief Operating Officer of Keros Therapeutics, Inc. and owns shares of Keros Therapeutics, Inc. (KROS) stock worth about $2.64M.
All Insider Reports: All Insider Reports

Ownership of Christopher Rovaldi

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
KROS	Keros Therapeutics, Inc.	Chief Operating Officer	$2.64M			Feb 18, 2025

Insider Transactions Reported by Christopher Rovaldi:

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.